FBN2 and neoplasm: As oncogenes, EMP1, UAP1L1, ETV5, CES1, and FBN2 promote tumor deterioration through immune escape, invasion and metastasis, and chemotherapy resistance (Wang Q. et al., 2025; Wu et al., 2022; di Martino et al., 2019; Wang JF.